SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 29.30+2.1%3:49 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: waverider who wrote (1918)4/30/1998 5:56:00 PM
From: wlheatmoon  Read Replies (1) of 5736
 
The heel stick blood draw does test for other problems in newborns other than bilirubin. However, if bilirubin is noted to be a problem, there is continuous testing until the problem resolves. CCSI's device can be used to eliminate the invasive monitoring. It can even be used as a portable device to determine the infant's bilirubin levels at home. Many infants are sent home after they're found to have elevated bilirubin and once treatments are initiated, the therapy can be continued at home. Instead of having the baby come to the clinic every day for bilirubin tests, a nurse can visit the family with this device and determine the level noninvasively. That's just one scenario. Another one is obviously for infants in the hospital. Once the bilirubin level is noted to be elevated, CCSI's noninvasive device can be used for monitoring the level and for determining the efficacy of therapy.

Just my thoughts. Good luck.

mike

PS--OH YES, HIGHER LOWS LOL, it has been a long day!!

<GGG>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext